1-8 of 8
Ronald A. Lubet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo

Hua Xie, Mee-Hyun Lee, Feng Zhu, Kanamata Reddy, Zunnan Huang, Dong Joon Kim, Yan Li, Cong Peng, Do Young Lim, Soouk Kang, Sung Keun Jung, Xiang Li, Haitao Li, Weiya Ma, Ronald A. Lubet, Jian Ding, Ann M. Bode, Zigang Dong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 950–958.
https://doi.org/10.1158/1535-7163.MCT-12-1241
Published: 09 June 2013
View article titled, Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities <em>In Vitro</em> and <em>In Vivo</em> in another window
Journal Articles

Abstract A82: Bardoxolone (5MeCDDO), which induces the antioxidant response element (ARE), is ineffective in inhibiting cancer progression but inhibits cancer initiation in rodent models of cancer. What does it mean for the ARE as a primary prevention target?

Ronald A. Lubet, Reid Townsend, Margie L. Clapper, Vernon E. Steele, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A82.
https://doi.org/10.1158/1535-7163.TARG-11-A82
Published: 12 November 2011
View article titled, Abstract A82: Bardoxolone (5MeCDDO), which induces the antioxidant response element (ARE), is ineffective in inhibiting cancer progression but inhibits cancer initiation in rodent models of cancer. What does it mean for the ARE as a primary prevention target?
Journal Articles

Chemopreventive Effects of Pioglitazone on Chemically Induced Lung Carcinogenesis in Mice

Yian Wang, Michael James, Weidong Wen, Yan Lu, Eva Szabo, Ronald A. Lubet, Ming You
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (11): 3074–3082.
https://doi.org/10.1158/1535-7163.MCT-10-0510
Published: 09 November 2010
View article titled, Chemopreventive Effects of Pioglitazone on Chemically Induced Lung Carcinogenesis in Mice
Open the PDF for Chemopreventive Effects of Pioglitazone on Chemically Induced Lung Carcinogenesis in Mice in another window
Journal Articles

Abstract A92: Chemoprevention of small cell lung carcinomas in mice by the retinoid X receptor agonist bexarotene

Yian Wang, Weidong Wen, Yijun Yi, Zhongqiu Zhang, Ronald A. Lubet, Ming You
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A92.
https://doi.org/10.1158/1535-7163.TARG-09-A92
Published: 10 December 2009
View article titled, Abstract A92: Chemoprevention of small cell lung carcinomas in mice by the retinoid X receptor agonist bexarotene
Journal Articles

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 972–979.
https://doi.org/10.1158/1535-7163.MCT-07-2141
Published: 15 April 2008
View article titled, Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Open the PDF for Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes in another window
Journal Articles

Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

Ronald A. Lubet, Chung S. Yang, Mao-Jung Lee, Yukihiko Hara, Izet M. Kapetanovic, James A. Crowell, Vernon E. Steele, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (7): 2022–2028.
https://doi.org/10.1158/1535-7163.MCT-07-0058
Published: 09 July 2007
View article titled, Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols
Open the PDF for Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols in another window
Journal Articles

Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide

Yian Wang, Ruisheng Yao, Anna Maciag, Clinton J. Grubbs, Ronald A. Lubet, Ming You
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 1060–1072.
https://doi.org/10.1158/1535-7163.MCT-05-0322
Published: 28 April 2006
View article titled, Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide
Open the PDF for Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide in another window
Journal Articles

Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations

Ronald A. Lubet, Konstantin Christov, Ming You, Ruisheng Yao, Vernon E. Steele, David W. End, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 1073–1078.
https://doi.org/10.1158/1535-7163.MCT-05-0398
Published: 28 April 2006
View article titled, Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations
Open the PDF for Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations in another window